Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Lacey David L., Director. Director active across 1 company, notably Arcus Biosciences, Inc.. Aggregated, 6 reports have been published. Activity tracked since 3 June 2021. The latest transaction was filed on 10 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
David L. Lacey is a Board Member at Arcus Biosciences, Inc. He plays a key role in overseeing the activities and strategy of the company. Lacey is recognized for his expertise in the biotechnology field.